NCT05870059

Brief Summary

The goal of this clinical trial is to compare the efficacy of Propolis mouthwash with 0.2% Chlorhexidine mouthwash as an adjunct to mechanical therapy in improving the status of periodontal disease in peri-menopausal women. The main question it aims to answer are:

  • Will propolis mouthwash be equal to Chlorhexidine mouthwash in improving the periodontal status of perimenopausal women?
  • Can neopterin be used as an indicator of periodontal disease. Participants will be asked questions about their general health, menstrual health and oral health then scaling will be done. After that participants will give saliva sample by spitting in a given container. Participants will be divided into 2 groups for treatment and each group comprised of 51 participants. Group 1: 20% Propolis mouthwash, twice a day for 6 weeks. Group 2: 0.2% chlorhexidine mouthwash, twice a day for 6 weeks.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
102

participants targeted

Target at P50-P75 for phase_2

Timeline
Completed

Started Feb 2022

Shorter than P25 for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 2, 2022

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 4, 2022

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 16, 2022

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

April 11, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

May 23, 2023

Completed
Last Updated

May 23, 2023

Status Verified

May 1, 2023

Enrollment Period

5 months

First QC Date

April 11, 2023

Last Update Submit

May 19, 2023

Conditions

Outcome Measures

Primary Outcomes (3)

  • Change in periodontal pocket depth.

    Measured in mm using calibrated williams periodontal probe.

    baseline,6 weeks, 12 weeks.

  • Change in clinical attachment loss.

    Measured in mm using calibrated williams periodontal probe.

    baseline,6 weeks, 12 weeks

  • change in Bleeding on probing.

    Presence or absence of blood in gingival pockets on probing.

    baseline,6 weeks, 12 weeks

Secondary Outcomes (1)

  • Change in salivary neopterin levels.

    baseline and 12 weeks.

Study Arms (2)

propolis

EXPERIMENTAL

5 ml of 20% propolis mouthwash twice a day.

Drug: Propolis mouthwash

chlorhexidine

ACTIVE COMPARATOR

5 ml of 0.2% chlorhexidine mouthwash twice a day.

Drug: Chlorhexidine mouthwash

Interventions

After scaling and root planning at the baseline visit, patients were prescribed to use 5ml of propolis mouthwash twice a day for 6 weeks. patients were also prescribed to not eat and drink anything for half an hour after the rinse.

propolis

After scaling and root planning at the baseline visit, patients were prescribed to use chlorhexidine mouthwash twice a day for 6 weeks. patients were also prescribed to not eat and drink anything for half an hour after the rinse.

Also known as: clinica mouthwash
chlorhexidine

Eligibility Criteria

Age40 Years - 50 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility Detailsour participants comprises of peri-menopausal population so only the female candidates were selected.
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Females of age 40-50 years.
  • Patients who are willing to receive treatment and give informed consent.
  • Patients with probing pocket depth (PPD) of 4mm - 5mm and clinical attachment loss (CAL) of 1-4 mm.
  • Presence of bleeding on probing (BOP).
  • Patients should not have been subject to periodontal therapy and antibiotic medication in the past 6 months.
  • Patients with a minimum of 20 teeth in the oral cavity.

You may not qualify if:

  • Patients who are allergic to honey products.
  • Patients on HRT (hormone replacement therapy) or patients who have not had a menstrual cycle for the last 12 months.
  • Patients who had lost teeth because of periodontal disease.
  • Patients who are or have been smokers in the past.
  • Patients are on any kind of antibiotic therapy at the time of screening.
  • Systemic conditions predispose patients to chronic periodontal diseases such as diabetes.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ziauddin University

Karachi, Sindh, Pakistan

Location

Related Publications (2)

  • Waqar SM, Huma A, Razi A, Saher F, Qureshi SS, Qureshi JA. FORMULATION DEVELOPMENT AND EVALUATION OF PROPOLIS MOUTHWASH FOR TREATMENT OF PERIODONTAL DISEASE.

    BACKGROUND
  • Waqar SM, Razi A, Qureshi SS, Saher F, Zaidi SJA, Kumar C. Comparative evaluation of propolis mouthwash with 0.2% chlorhexidine mouthwash as an adjunct to mechanical therapy in improving the periodontitis among perimenopausal women: a randomized controlled trial. BMC Oral Health. 2024 Jan 5;24(1):26. doi: 10.1186/s12903-023-03768-4.

MeSH Terms

Conditions

Periodontal Diseases

Condition Hierarchy (Ancestors)

Mouth DiseasesStomatognathic Diseases

Study Officials

  • Syeda M. Waqar, M.Phil

    Ziauddin University, shahrae ghalib, Clifton, Karachi. Pakistan.

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Masking Details
As this is going to be a double-blind study, a third person will dispense the Propolis mouthwash (prepared in Ziauddin College of pharmacy) and Chlorhexidine mouthwash (commercially available) into dark-colored bottles of the same size and shape. The third person will code the bottles as A or B and seal the codes with the product name in envelopes accordingly.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigstor

Study Record Dates

First Submitted

April 11, 2023

First Posted

May 23, 2023

Study Start

February 2, 2022

Primary Completion

July 4, 2022

Study Completion

November 16, 2022

Last Updated

May 23, 2023

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will not share

it was written in the consent form that no information regarding patients will be shared to anyone in any case considering the ethics.

Locations